DOCSLIB.ORG

Med14 (NM 001048208) Mouse Tagged ORF Clone Product Data

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Med14 (NM 001048208) Mouse Tagged ORF Clone Product Data OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for MG226706 Med14 (NM_001048208) Mouse Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Med14 (NM_001048208) Mouse Tagged ORF Clone Tag: TurboGFP Symbol: Med14 Synonyms: 9930001L01Rik; AU041628; Crsp2; ENSMUSG00000073278; Gm641; ORF1; Trap170 Vector: pCMV6-AC-GFP (PS100010) E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: Neomycin ORF Nucleotide >MG226706 representing NM_001048208 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGCCCCAGTGCAGCTGGACAACCACCAGCTGATCCCTCCTGGCGGCGGCGGTGGCAGCAGCGGCGGCG GAGGCAGCAGCAGCGGCTCCGCGTCTGCCCCGGCTCCCCCGCCGCCCGCAGCCGCTGTGGCGGCGGCAGC TGCGGCGGCAGCTAGCCCTGGATACCGGCTTAGCACGCTCATCGAATTTCTGCTCCACCGGGCCTACTCG GAGCTTATGGTGTTGACGGACTTATTGCCAAGGAAATCTGATGTGGAAAGGAAAATAGAAATTGTACAGT TTGCTAGCCGGACACGTCAACTCTTCGTTCGATTATTAGCTTTAGTAAAATGGGCCAATGACGCTGGCAA AGTAGAAAAGTGTGCGATGATCTCAAGCTTTTTAGATCAGCAAGCTATCTTATTTGTGGATACCGCTGAC CGCTTGGCCTCCTTAGCTAGAGATGCCCTGGTCCATGCACGCCTGCCTAGTTTTGCTATTCCATATGCCA TTGATGTACTGACTACTGGCTCTTATCCACGGCTTCCAACCTGCATCAGGGACAAAATTATTCCTCCAGA CCCAATTACCAAAATTGAGAAACAAGCCACACTTCATCAGCTTAATCAGATTCTTAGACATAGGCTTGTA ACGACAGATCTTCCTCCACAGCTAGCAAATCTTACAGTGGCAAATGGCCGTGTGAAGTTTCGAGTTGAAG GAGAATTTGAAGCAACCTTGACAGTGATGGGTGATGACCCAGAAGTCCCGTGGCGTCTTCTCAAGCTAGA AATTCTAGTTGAGGATAAGGAAACAGGAGATGGGCGAGCTTTGGTTCATAGCATGCAAATCGATTTTATC CATCAGCTGGTCCAGTCTAGGCTCTTTGCTGATGAGAAACCTCTTCAGGACATGTACAACTGCCTACATT GTTTCTGCTTATCGCTTCAACTAGAAGTATTACATTCCCAGACACTAATGTTAATCCGAGAGAGGTGGGG AGACCTTGTACAGGTGGAAAGATACCATGCTGGAAAGAGCCTCTCCCTCTCAGTTTGGAATCAACAGGTT CTAGGGAGAAAAACAGGCACAGCATCTGTTCACAAAGTTACAATTAAAATCGATGAGAATGATGTCTCCA AGCCTTTACAGATTTTTCATGATCCTCCTTTGCCAGCTTCTGATTCTAAATTAGTAGAAAGAGCCATGAA GATTGACCACTTATCAATAGAAAAGCTCCTGATTGACAGTGTACACGCAAGAGCCCACCAGAGGCTGCAG GAACTGAAGGCCATTCTTAGAAGCTTCAACGCCAATGAAAGCTCTTCCATAGAGACTGCACTTCCAGCTC TTATTGTACCCATCTTGGAGCCTTGTGGTAATTCGGAGTGCCTACACATTTTTGTAGATTTGCATTCTGG AATGTTCCAATTGATGCTTTATGGACTTGACCCAGCCACTCTGGAGGACATGGAAAAATCTTTGAATGAT GACATGAAGCGGATCATCCCTTGGATTCAGCAACTTAAGTTTTGGCTGGGACAACAGCGTTGCAAACAAT This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 5 Med14 (NM_001048208) Mouse Tagged ORF Clone – MG226706 CTATAAAACATCTGCCTACAATAACCACTGAAACGTTGCAGCTTGCCAACTATTCAACACATCCCATTGG AAGCCTTTCTAAGAATAAGCTGTTTATTAAACTTACTCGCCTTCCACAGTACTACATTGTTGTGGAAATG CTTGAGGTTCCTAATAAGCCTACGCAGCTATCATATAACTATTACTTTATGTCGGTGAGTACTGCAGATC GTGAGGACAGCCCTGTCATGGCACTGCTGCTGCAGCAATTCAAGGACAACATCCAGGACCTGATGTCCTA TACAAAGACTGGGAAACAGACCAGAACTGGTACCAAGCACAAGTTGTCTGATGACCCATGTCCGATAGAC TCCAAGAAAGCCAAACGATCAGGAGAAATGTGTGCCTTCAATAAAGTTCTAGCTCACTTTGTTGCTATGT GTGACACCAACATGCCATTTGTTGGTCTTCGATTGGAGTTGTCTAACCTCGAGATACCACATCAGGGAGT GCAAGTGGAAGGTGATGGCTTCAACCATGCAATTCGCTTATTAAAGATTCCTCCCTGTAAAGGAATAAGT GAGGAAACACAGAAGGCTCTGGACCGCTCTCTTCTTGATTGCACTTTCCGATTACAAGGTAGAAATAACC GCACTTGGGTGGCTGAATTAGTGTTTGCAAATTGTCCGCTTAATGGCACTTCCACCAGGGAGCAAGGACC ATCCCGACATGTTTACCTGACGTATGAAAATTTGTTGTCTGAACCTGTTGGTGGCAGAAAAGTAGTTGAA ATGTTTCTTAATGACTGGAGTAGCATTGCCCGTTTATACGAGTGTGTGTTGGAATTTGCACGTTCTCTAC CAGAAATACCTGCTCATCTGAATATTTTCTCAGAAGTTCGTGTTTATAATTATCGAAAGCTTATCTTATG TTATGGAACCACCAAAGGAAGCTCAATTAGTATTCAGTGGAACTCCATTCATCAGAAATTTCACATTGCG TTGGGAACAGTTGGCCCAAACTCAGGTTGCAGTAACTGTCACAATACCATTCTCCATCAACTTCAAGAAA TGTTCAACAAAACACCAAATGTGGTTCAGTTATTACAGGTTTTGTTTGATACTCAGGCACCATTAAATGC TATCAACAAACTCCCTACTGTTCCAATGTTGGGCTTGACCCAGAGAACTAACACCGCCTACCAGTGTTTC TCCATTTTACCACAATCATCCACCCACATCAGACTGGCCTTCAGGAACATGTACTGCATTGACATATACT GCCGTAGTCGAGGCGTCGTGGCAATACGGGACGGTGCCTATAGTCTTTTTGATAACAGCAAGTTAGTTGA AGGCTTCTATCCTGCACCAGGATTAAAGACTTTCCTGAACATGTTTGTTGATAGCAATCAAGATGCTCGG AGAAGATCTGTAAATGAGGATGATAACCCTCCTTCTCCTATAGGAGGTGACATGATGGACTCTTTAATAT CACAGCTCCAGCCACCTCAGCAACAGCCATTTCCAAAGCAGCCAGGGACATCAGGCGCTTACCCTCTTAC TTCACCCCCTACATCCTATCACAGCACAGTTAATCAGTCCCCCTCTATGATGCACACACAGTCTCCAGGA AATCTGCATGCTGCCAGCTCCCCCAGTGGGGCTTTGAGAGCCCCATCACCAGCGTCATTTGTTCCAACTC CTCCCCCATCCTCGCATGGAATCTCAATAGGACCAGGGGCCAGTTTTGCTAGTCCACATGGAACCCTTGA CCCTAGTTCTCCATATACTATGGTGTCACCAAGTGGACGAGCAGGAAACTGGCCTGGGTCACCTCAAGTG TCCGGACCCTCACCAGCAACCCGTTTGCCTGGAATGTCACCAGCTAACCCATCTCTGCATTCTCCTGTTC CAGATGTTTCTCATTCTCCTCGAGCTGGCACAAGTTCCCAGACAATGCCAACCAACATGCCTCCACCTCG AAAACTACCTCAGCGCTCCTGGGCAGCATCTATACCCACCATTCTCACTCATAGTGCCTTGAACATCTTA CTGCTACCATCTCCAACGCCAGGCCTTGTGCCTGGCCTGGCAGGTAGTTACCTTTGTTCCCCACTTGAGA GATTCCTTGGATCTGTCATCATGAGACGACACCTTCAAAGAATCATCCAACAGGAAACGTTGCAGCTGAT CAATTCCAATGAACCTGGTGTAATCATGTTCAAGACAGATGCCCTGAAATGCAGAGTAGCCCTTAGTCCC AAAACCAACCAGACCCTTCAGCTAAAAGTGACACCTGAAAATGCAGGACAATGGAAACCCGATGAGCTTC AAGTTTTGGAGAAATTCTTCGAAACAAGAGTTGCAGGACCGCCATTTAAAGCCAACACACTTATAGCCTT CACCAAGCTGTTGGGAGCGCCGACACACATCCTCCGGGACTGTGTGCATATAATGAAGTTGGAGTTGTTC CCAGATCAAGCAACGCAGCTGAAATGGAACGTTCAGTTTTGCCTCACCATCCCTCCCAGCGCACCACCAA TTGCACCGCCTGGGACACCAGCTGTGGTCCTGAAATCCAAAATGCTATTTTTTCTTCAACTAACTCAGAA AACATCAGTCCCTCCCCAAGAACCTGTTAGTATAATAGTTCCAATTATTTATGATATGGCTTCAGGTACC ACTCAGCAGGCAGACATTCCCAGACAGCAGAACTCTTCTGTTGCTGCGCCAATGATGGTCAGCAACATTC TGAAGAGGTTTGCAGAGATGAACCCTCCACGACAAGGTGAATGCACAATATTTGCAGCTGTTCGTGATTT AATGGCTAATCTTACACTGCCCCCTGGTGGGCGTCCA ACGCGTACGCGGCCGCTCGAG - GFP Tag - GTTTAA This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 2 / 5 Med14 (NM_001048208) Mouse Tagged ORF Clone – MG226706 Protein Sequence: >MG226706 representing NM_001048208 Red=Cloning site Green=Tags(s) MAPVQLDNHQLIPPGGGGGSSGGGGSSSGSASAPAPPPPAAAVAAAAAAAASPGYRLSTLIEFLLHRAYS ELMVLTDLLPRKSDVERKIEIVQFASRTRQLFVRLLALVKWANDAGKVEKCAMISSFLDQQAILFVDTAD RLASLARDALVHARLPSFAIPYAIDVLTTGSYPRLPTCIRDKIIPPDPITKIEKQATLHQLNQILRHRLV TTDLPPQLANLTVANGRVKFRVEGEFEATLTVMGDDPEVPWRLLKLEILVEDKETGDGRALVHSMQIDFI HQLVQSRLFADEKPLQDMYNCLHCFCLSLQLEVLHSQTLMLIRERWGDLVQVERYHAGKSLSLSVWNQQV LGRKTGTASVHKVTIKIDENDVSKPLQIFHDPPLPASDSKLVERAMKIDHLSIEKLLIDSVHARAHQRLQ ELKAILRSFNANESSSIETALPALIVPILEPCGNSECLHIFVDLHSGMFQLMLYGLDPATLEDMEKSLND DMKRIIPWIQQLKFWLGQQRCKQSIKHLPTITTETLQLANYSTHPIGSLSKNKLFIKLTRLPQYYIVVEM LEVPNKPTQLSYNYYFMSVSTADREDSPVMALLLQQFKDNIQDLMSYTKTGKQTRTGTKHKLSDDPCPID SKKAKRSGEMCAFNKVLAHFVAMCDTNMPFVGLRLELSNLEIPHQGVQVEGDGFNHAIRLLKIPPCKGIS EETQKALDRSLLDCTFRLQGRNNRTWVAELVFANCPLNGTSTREQGPSRHVYLTYENLLSEPVGGRKVVE MFLNDWSSIARLYECVLEFARSLPEIPAHLNIFSEVRVYNYRKLILCYGTTKGSSISIQWNSIHQKFHIA LGTVGPNSGCSNCHNTILHQLQEMFNKTPNVVQLLQVLFDTQAPLNAINKLPTVPMLGLTQRTNTAYQCF SILPQSSTHIRLAFRNMYCIDIYCRSRGVVAIRDGAYSLFDNSKLVEGFYPAPGLKTFLNMFVDSNQDAR RRSVNEDDNPPSPIGGDMMDSLISQLQPPQQQPFPKQPGTSGAYPLTSPPTSYHSTVNQSPSMMHTQSPG NLHAASSPSGALRAPSPASFVPTPPPSSHGISIGPGASFASPHGTLDPSSPYTMVSPSGRAGNWPGSPQV SGPSPATRLPGMSPANPSLHSPVPDVSHSPRAGTSSQTMPTNMPPPRKLPQRSWAASIPTILTHSALNIL LLPSPTPGLVPGLAGSYLCSPLERFLGSVIMRRHLQRIIQQETLQLINSNEPGVIMFKTDALKCRVALSP KTNQTLQLKVTPENAGQWKPDELQVLEKFFETRVAGPPFKANTLIAFTKLLGAPTHILRDCVHIMKLELF PDQATQLKWNVQFCLTIPPSAPPIAPPGTPAVVLKSKMLFFLQLTQKTSVPPQEPVSIIVPIIYDMASGT TQQADIPRQQNSSVAAPMMVSNILKRFAEMNPPRQGECTIFAAVRDLMANLTLPPGGRP TRTRPLE - GFP Tag - V Restriction Sites: SgfI-MluI Cloning Scheme: This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 3 / 5 Med14 (NM_001048208) Mouse Tagged ORF Clone – MG226706 Plasmid Map: ACCN: NM_001048208 ORF Size: 4377 bp OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_001048208.1, NP_001041673.1 RefSeq Size: 6861 bp RefSeq ORF: 4380 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 4 / 5 Med14 (NM_001048208) Mouse Tagged ORF Clone – MG226706 Locus ID: 26896 UniProt ID: A2ABV5 Gene Summary: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors (By similarity). [UniProtKB/Swiss-Prot Function] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 5 / 5.
Load more

Recommended publications
  • Essential Genes and Their Role in Autism Spectrum Disorder
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Essential Genes And Their Role In Autism Spectrum Disorder Xiao Ji University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, and the Genetics Commons Recommended Citation Ji, Xiao, "Essential Genes And Their Role In Autism Spectrum Disorder" (2017). Publicly Accessible Penn Dissertations. 2369. https://repository.upenn.edu/edissertations/2369 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2369 For more information, please contact [email protected]. Essential Genes And Their Role In Autism Spectrum Disorder Abstract Essential genes (EGs) play central roles in fundamental cellular processes and are required for the survival of an organism. EGs are enriched for human disease genes and are under strong purifying selection. This intolerance to deleterious mutations, commonly observed haploinsufficiency and the importance of EGs in pre- and postnatal development suggests a possible cumulative effect of deleterious variants in EGs on complex neurodevelopmental disorders. Autism spectrum disorder (ASD) is a heterogeneous, highly heritable neurodevelopmental syndrome characterized by impaired social interaction, communication and repetitive behavior. More and more genetic evidence points to a polygenic model of ASD and it is estimated that hundreds of genes contribute to ASD. The central question addressed in this dissertation is whether genes with a strong effect on survival and fitness (i.e. EGs) play a specific oler in ASD risk. I compiled a comprehensive catalog of 3,915 mammalian EGs by combining human orthologs of lethal genes in knockout mice and genes responsible for cell-based essentiality.
    [Show full text]
  • Identification of Protein Complexes Associated with Myocardial Infarction Using a Bioinformatics Approach
    MOLECULAR MEDICINE REPORTS 18: 3569-3576, 2018 Identification of protein complexes associated with myocardial infarction using a bioinformatics approach NIANHUI JIAO1, YONGJIE QI1, CHANGLI LV2, HONGJUN LI3 and FENGYONG YANG1 1Intensive Care Unit; 2Emergency Department, Laiwu People's Hospital, Laiwu, Shandong 271199; 3Emergency Department, The Central Hospital of Tai'an, Tai'an, Shandong 271000, P.R. China Received November 3, 2016; Accepted January 3, 2018 DOI: 10.3892/mmr.2018.9414 Abstract. Myocardial infarction (MI) is a leading cause of clinical outcomes regarding high-risk MI. For example, muta- mortality and disability worldwide. Determination of the tions in the myocardial infarction-associated transcript have molecular mechanisms underlying the disease is crucial for been reported to cause susceptibility to MI (5). In addition, it identifying possible therapeutic targets and designing effective was demonstrated that mutations in the oxidized low-density treatments. On the basis that MI may be caused by dysfunc- lipoprotein receptor 1 gene may significantly increase the tional protein complexes rather than single genes, the present risk of MI (6). Although some MI-related genes have been study aimed to use a bioinformatics approach to identifying detected, many were identified independently and functional complexes that may serve important roles in the develop- associations among the genes have rarely been explored. ment of MI. By investigating the proteins involved in these Therefore, it is necessary to investigate MI from a systematic identified complexes, numerous proteins have been reported perspective, as the complex disease was reported to occur due that are related to MI, whereas other proteins interacted to the dysregulation of functional gene sets (7).
    [Show full text]
  • Differential Requirement of MED14 and UVH6 for Heterochromatin Transcription Upon Destabilization of Silencing
    bioRxiv preprint doi: https://doi.org/10.1101/407015; this version posted September 3, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Differential requirement of MED14 and UVH6 for heterochromatin transcription upon destabilization of silencing Pierre Bourguet1, Stève de Bossoreille1,2†, Leticia López-González1†, Marie-Noëlle Pouch-Pélissier1, Ángeles Gómez-Zambrano1,3, Anthony Devert1, Thierry Pélissier1, Romain Pogorelcnik1, Isabelle Vaillant1, Olivier Mathieu1* 1 Université Clermont Auvergne, CNRS, Inserm, Génétique Reproduction et Développement (GReD), F-63000 Clermont- Ferrand, France 2 Present address: Laboratoire Reproduction et Développement des Plantes, Université de Lyon, ENS de Lyon, UCB Lyon 1, CNRS, INRA, F-69342, Lyon, France 3 Present address: Instituto de Bioquímica Vegetal y Fotosíntesis, CSIC-Cartuja, Avda. Américo Vespucio, 49. 41092- Sevilla- Spain † These authors contributed equally to this work * Corresponding author. Tel: 33 473 407 407, E-mail: [email protected] Abstract Constitutive heterochromatin is commonly associated with high levels of repressive epigenetic marks and is stably maintained transcriptionally silent by the concerted action of different, yet convergent, silencing pathways. Reactivation of heterochromatin transcription is generally associated with alterations in levels of these epigenetic marks. However, in mutants for particular epigenetic regulators, or upon particular environmental changes such as heat stress, heterochromatin-associated silencing is destabilized without noticeable changes in epigenetic marks. This suggests that transcription can occur in a non-permissive chromatin context, yet the factors involved remain poorly known.
    [Show full text]
  • A Role for MED14 and UVH6 in Heterochromatin Transcription Upon Destabilization of Silencing
    Published Online: 12 December, 2018 | Supp Info: http://doi.org/10.26508/lsa.201800197 Downloaded from life-science-alliance.org on 28 January, 2019 Research Article A role for MED14 and UVH6 in heterochromatin transcription upon destabilization of silencing Pierre Bourguet , Stève de Bossoreille* , Leticia López-Gonzalez*,´ Marie-Noelle¨ Pouch-Pelissier´ , Angeles´ Gómez-Zambrano, Anthony Devert, Thierry Pelissier,´ Romain Pogorelcnik, Isabelle Vaillant, Olivier Mathieu Constitutive heterochromatin is associated with repressive epi- dimethylation at histone H3 lysine 9 (H3K9me2) or monomethylation of genetic modifications of histones and DNA which silence tran- H3K27 (H3K27me1) (Feng & Michaels, 2015). These epigenetic marks scription. Yet, particular mutations or environmental changes can typically contribute to maintaining heterochromatin compaction and destabilize heterochromatin-associated silencing without notice- transcriptional inactivity. In Arabidopsis, H3K27me1 is catalyzed by the able changes in repressive epigenetic marks. Factors allowing histone methyltransferases Arabidopsis trithorax-related protein 5 transcription in this nonpermissive chromatin context remain (ATXR5) and ATXR6 (Jacob et al, 2009). H3K9me2 is deposited by the poorly known. Here, we show that the transcription factor IIH histone methyltransferases kryptonite (KYP)/SU(VAR)39 homolog 4 component UVH6 and the mediator subunit MED14 are both re- (SUVH4), SUVH5, and SUVH6. In plants, cytosine DNA methylation quired for heat stress–induced transcriptional changes and release occurs in three nucleotide sequence contexts: CG, CHG, and CHH, of heterochromatin transcriptional silencing in Arabidopsis thali- where H is any base but a guanine. CG methylation is maintained ana.Wefind that MED14, but not UVH6, is required for transcription during DNA replication, where methyltransferase 1 (MET1) reproduces when heterochromatin silencing is destabilized in the absence of the CG methylation pattern from the template strand to the neo- stress through mutating the MOM1 silencing factor.
    [Show full text]
  • Glucocorticoid Receptor Condensates Link DNA-Dependent Receptor 2 Dimerization and Transcriptional Transactivation 3 4 5 Filipp Frank1*, Xu Liu1, Eric A
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.10.376327; this version posted November 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Glucocorticoid receptor condensates link DNA-dependent receptor 2 dimerization and transcriptional transactivation 3 4 5 Filipp Frank1*, Xu Liu1, Eric A. Ortlund1* 6 1Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA 7 8 *Corresponding author: 9 Filipp Frank, 10 [email protected], 11 Emory University, 12 Department of Biochemistry, 13 1510 Clifton Rd. NE, Atlanta, GA, 30322, USA. 14 15 Eric A. Ortlund, 16 [email protected], 17 Emory University, 18 Department of Biochemistry, 19 1510 Clifton Rd. NE, Atlanta, GA, 30322, USA. bioRxiv preprint doi: https://doi.org/10.1101/2020.11.10.376327; this version posted November 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 20 Abstract 21 The glucocorticoid receptor (GR) is a ligand-regulated transcription factor (TF) that controls the 22 tissue- and gene-specific transactivation and transrepression of thousands of target genes. 23 Distinct GR DNA binding sequences with activating or repressive activities have been identified, 24 but how they modulate transcription in opposite ways is not known. We show that GR forms 25 phase-separated condensates that specifically concentrate known co-regulators via their 26 intrinsically disordered regions (IDRs) in vitro. A combination of dynamic, multivalent (between 27 IDRs) and specific, stable interactions (between LxxLL motifs and the GR ligand binding domain) 28 control the degree of recruitment.
    [Show full text]
  • Chromatin Occupancy and Target Genes of the Haematopoietic Master Transcription Factor MYB Roza B
    www.nature.com/scientificreports OPEN Chromatin occupancy and target genes of the haematopoietic master transcription factor MYB Roza B. Lemma1,2,8, Marit Ledsaak1,3,8, Bettina M. Fuglerud1,4,5, Geir Kjetil Sandve6, Ragnhild Eskeland1,3,7 & Odd S. Gabrielsen1* The transcription factor MYB is a master regulator in haematopoietic progenitor cells and a pioneer factor afecting diferentiation and proliferation of these cells. Leukaemic transformation may be promoted by high MYB levels. Despite much accumulated molecular knowledge of MYB, we still lack a comprehensive understanding of its target genes and its chromatin action. In the present work, we performed a ChIP-seq analysis of MYB in K562 cells accompanied by detailed bioinformatics analyses. We found that MYB occupies both promoters and enhancers. Five clusters (C1–C5) were found when we classifed MYB peaks according to epigenetic profles. C1 was enriched for promoters and C2 dominated by enhancers. C2-linked genes were connected to hematopoietic specifc functions and had GATA factor motifs as second in frequency. C1 had in addition to MYB-motifs a signifcant frequency of ETS-related motifs. Combining ChIP-seq data with RNA-seq data allowed us to identify direct MYB target genes. We also compared ChIP-seq data with digital genomic footprinting. MYB is occupying nearly a third of the super-enhancers in K562. Finally, we concluded that MYB cooperates with a subset of the other highly expressed TFs in this cell line, as expected for a master regulator. Te transcription factor c-Myb (approved human symbol MYB), encoded by the MYB proto-oncogene, is highly expressed in haematopoietic progenitor cells and plays a key role in regulating the expression of genes involved in diferentiation and proliferation of myeloid and lymphoid progenitors 1–5.
    [Show full text]
  • Lethal Mitochondrial Cardiomyopathy in a Hypomorphic Med30 Mouse Mutant Is Ameliorated by Ketogenic Diet
    Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet Philippe Krebsa,1, Weiwei Fanb, Yen-Hui Chenc, Kimimasa Tobitad, Michael R. Downesb, Malcolm R. Woode, Lei Suna, Xiaohong Lia, Yu Xiaa, Ning Dingb, Jason M. Spaethf, Eva Marie Y. Morescoa, Thomas G. Boyerf, Cecilia Wen Ya Lod, Jeffrey Yenc, Ronald M. Evansb, and Bruce Beutlera,2,3 aDepartment of Genetics and eCore Microscopy Facility, The Scripps Research Institute, La Jolla, CA 92037; bThe Salk Institute, Howard Hughes Medical Institute, La Jolla, CA 92037; cInstitute of Biomedical Sciences, Academia Sinica, 11529 Taipei, Taiwan; dDepartment of Developmental Biology, Rangos Research Center, Pittsburgh, PA 15201; and fDepartment of Molecular Medicine, University of Texas Health Science Center, San Antonio, TX 78245 Contributed by Bruce Beutler, October 31, 2011 (sent for review September 24, 2011) Deficiencies of subunits of the transcriptional regulatory complex sociated with any phenotype in living organisms. In contrast to Mediator generally result in embryonic lethality, precluding study of other models with Mediator deficiencies, homozygous zeitgeist its physiological function. Here we describe a missense mutation in mice are physically indistinguishable from littermates at the time Med30 causing progressive cardiomyopathy in homozygous mice of weaning, but develop progressive cardiomyopathy that is in- that, although viable during lactation, show precipitous lethality 2– variably fatal by 7 wk of age. Mechanistically, the Med30zg mutation 3 wk after weaning. Expression profiling reveals pleiotropic changes causes a progressive and selective decline in the transcription of in transcription of cardiac genes required for oxidative phosphoryla- genes necessary for oxidative phosphorylation (OXPHOS) and tion and mitochondrial integrity.
    [Show full text]
  • Agricultural University of Athens
    ΓΕΩΠΟΝΙΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΤΩΝ ΖΩΩΝ ΤΜΗΜΑ ΕΠΙΣΤΗΜΗΣ ΖΩΙΚΗΣ ΠΑΡΑΓΩΓΗΣ ΕΡΓΑΣΤΗΡΙΟ ΓΕΝΙΚΗΣ ΚΑΙ ΕΙΔΙΚΗΣ ΖΩΟΤΕΧΝΙΑΣ ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ Εντοπισμός γονιδιωματικών περιοχών και δικτύων γονιδίων που επηρεάζουν παραγωγικές και αναπαραγωγικές ιδιότητες σε πληθυσμούς κρεοπαραγωγικών ορνιθίων ΕΙΡΗΝΗ Κ. ΤΑΡΣΑΝΗ ΕΠΙΒΛΕΠΩΝ ΚΑΘΗΓΗΤΗΣ: ΑΝΤΩΝΙΟΣ ΚΟΜΙΝΑΚΗΣ ΑΘΗΝΑ 2020 ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ Εντοπισμός γονιδιωματικών περιοχών και δικτύων γονιδίων που επηρεάζουν παραγωγικές και αναπαραγωγικές ιδιότητες σε πληθυσμούς κρεοπαραγωγικών ορνιθίων Genome-wide association analysis and gene network analysis for (re)production traits in commercial broilers ΕΙΡΗΝΗ Κ. ΤΑΡΣΑΝΗ ΕΠΙΒΛΕΠΩΝ ΚΑΘΗΓΗΤΗΣ: ΑΝΤΩΝΙΟΣ ΚΟΜΙΝΑΚΗΣ Τριμελής Επιτροπή: Aντώνιος Κομινάκης (Αν. Καθ. ΓΠΑ) Ανδρέας Κράνης (Eρευν. B, Παν. Εδιμβούργου) Αριάδνη Χάγερ (Επ. Καθ. ΓΠΑ) Επταμελής εξεταστική επιτροπή: Aντώνιος Κομινάκης (Αν. Καθ. ΓΠΑ) Ανδρέας Κράνης (Eρευν. B, Παν. Εδιμβούργου) Αριάδνη Χάγερ (Επ. Καθ. ΓΠΑ) Πηνελόπη Μπεμπέλη (Καθ. ΓΠΑ) Δημήτριος Βλαχάκης (Επ. Καθ. ΓΠΑ) Ευάγγελος Ζωίδης (Επ.Καθ. ΓΠΑ) Γεώργιος Θεοδώρου (Επ.Καθ. ΓΠΑ) 2 Εντοπισμός γονιδιωματικών περιοχών και δικτύων γονιδίων που επηρεάζουν παραγωγικές και αναπαραγωγικές ιδιότητες σε πληθυσμούς κρεοπαραγωγικών ορνιθίων Περίληψη Σκοπός της παρούσας διδακτορικής διατριβής ήταν ο εντοπισμός γενετικών δεικτών και υποψηφίων γονιδίων που εμπλέκονται στο γενετικό έλεγχο δύο τυπικών πολυγονιδιακών ιδιοτήτων σε κρεοπαραγωγικά ορνίθια. Μία ιδιότητα σχετίζεται με την ανάπτυξη (σωματικό βάρος στις 35 ημέρες, ΣΒ) και η άλλη με την αναπαραγωγική
    [Show full text]
  • Flightless-I Mediates the Repression of Estrogen Receptor Α Target Gene Expression by the Glucocorticoid Receptor in MCF-7 Cells
    2019, 66 (1), 65-74 Original Flightless-I mediates the repression of estrogen receptor α target gene expression by the glucocorticoid receptor in MCF-7 cells Liu Yang and Kwang Won Jeong Gachon Institute of Pharmaceutical Sciences, College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea Abstract. The human homologue of flightless-I (FLII) belong to the gelsolin protein family and contain a gelsolin-like domain at the C-terminus and a leucine-rich repeat (LRR) domain at the N-terminus. FLII regulates estrogen receptor alpha (ERα) and glucocorticoid receptor (GR)-mediated transcription by direct interaction through different domains, suggestive of its potential role in the crosstalk between the ERα and GR signaling pathway. Here, we demonstrate that FLII plays a critical role in GR-mediated repression of ERα target gene expression. In FLII-depleted cells, the reduction in 17-β-estradiol (E2)- induced ERα occupancy following treatment with dexamethasone (Dex) at the estrogen responsive element (ERE) site of the ERα target gene was significantly inhibited. The ERE binding of GR by the cotreatment with E2 and Dex was significantly inhibited by FLII depletion, indicating that FLII is required for the recruitment of GR at the ERE sites of ERα target genes. In addition, the recruitment of ERα-induced FLII to ERE sites was significantly reduced by Dex treatment. In protein binding assays, GR inhibited the E2-induced interaction between ERα and FLII, suggesting that GR interferes with the binding of ERα and FLII at the ERα target genes, resulting in the release of ERα and FLII from EREs.
    [Show full text]
  • Dynamic Reversal of Random X-Chromosome Inactivation During Ipsc Reprogramming
    Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Research Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming Adrian Janiszewski,1,5 Irene Talon,1,5 Joel Chappell,1 Samuel Collombet,2 Juan Song,1 Natalie De Geest,1 San Kit To,1 Greet Bervoets,3,4 Oskar Marin-Bejar,3,4 Caterina Provenzano,1 Lotte Vanheer,1 Jean-Christophe Marine,3,4 Florian Rambow,3,4 and Vincent Pasque1 1KU Leuven–University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, B-3000 Leuven, Belgium; 2European Molecular Biology Laboratory (EMBL), 69117 Heidelberg, Germany; 3Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, 3000 Leuven, Belgium; 4Department of Oncology, KU Leuven, 3000 Leuven, Belgium Induction and reversal of chromatin silencing is critical for successful development, tissue homeostasis, and the derivation of induced pluripotent stem cells (iPSCs). X-Chromosome inactivation (XCI) and reactivation (XCR) in female cells represent chromosome-wide transitions between active and inactive chromatin states. Although XCI has long been studied, providing important insights into gene regulation, the dynamics and mechanisms underlying the reversal of stable chromatin silencing of X-linked genes are much less understood. Here, we use allele-specific transcriptomics to study XCR during mouse iPSC re- programming in order to elucidate the timing and mechanisms of chromosome-wide reversal of gene silencing. We show that XCR is hierarchical, with subsets of genes reactivating early, late, and very late during reprogramming. Early genes are acti- vated before the onset of late pluripotency genes activation.
    [Show full text]
  • The Role of Cyclin-Dependent Kinase 8 in Vascular Disease Desiree Leach University of South Carolina
    University of South Carolina Scholar Commons Theses and Dissertations Fall 2017 The Role Of Cyclin-Dependent Kinase 8 In Vascular Disease Desiree Leach University of South Carolina Follow this and additional works at: https://scholarcommons.sc.edu/etd Part of the Biomedical and Dental Materials Commons Recommended Citation Leach, D.(2017). The Role Of Cyclin-Dependent Kinase 8 In Vascular Disease. (Doctoral dissertation). Retrieved from https://scholarcommons.sc.edu/etd/4523 This Open Access Dissertation is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. THE ROLE OF CYCLIN -DEPENDENT KINASE 8 IN VASCULAR DISEASE by Desiree Leach Bachelor of Science Coastal Carolina University, 2010 Submitted in Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy in Biomedical Science School of Medicine University of South Carolina 2017 Accepted by: Taixing Cui, Major Professor Wayne Carver, Committee Member Joseph Janicki, Committee Member Igor Roninson, Committee Member Udai Singh, Committee Member Cheryl L Addy, Vice Provost and Dean of the Graduate School © Copyright by Desiree Leach, 2017 All Rights Reserved. ii ACKNOWLEDGEMENTS I would like to thank my mentor, Dr. Taixing Cui, for all his guidance and support. Thank you for supplying me with the knowledge and techniques to grow as a scientist. I would also like to thank my committee members: Dr. Wayne Carver, Dr. Igor Roninson, Dr. Udai Singh and Dr. Joseph Janicki. I appreciate all of your constructive criticism and your efforts to help me grow as a scientist.
    [Show full text]
  • Glucocorticoid Receptor: a Multifaceted Actor in Breast Cancer
    International Journal of Molecular Sciences Review Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer Lara Malik Noureddine 1,2,3,4, Olivier Trédan 1,2,3,5, Nader Hussein 4, Bassam Badran 4, Muriel Le Romancer 1,2,3 and Coralie Poulard 1,2,3,* 1 Université de Lyon, F-69000 Lyon, France; [email protected] (L.M.N.); [email protected] (O.T.); [email protected] (M.L.R.) 2 Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France 3 CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France 4 Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences, Lebanese University, Hadat-Beirut 90656, Lebanon; [email protected] (N.H.); [email protected] (B.B.) 5 Centre Leon Bérard, Oncology Department, F-69000 Lyon, France * Correspondence: [email protected]; Tel.: +33-478-786-663; Fax: +33-478-782-720 Abstract: Breast cancer (BC) is one of the most common cancers in women worldwide. Even though the role of estrogen receptor alpha (ERα) is extensively documented in the development of breast tumors, other members of the nuclear receptor family have emerged as important players. Synthetic glucocorticoids (GCs) such as dexamethasone (dex) are commonly used in BC for their antiemetic, anti-inflammatory, as well as energy and appetite stimulating properties, and to manage the side effects of chemotherapy. However, dex triggers different effects depending on the BC subtype. The glucocorticoid receptor (GR) is also an important marker in BC, as high GR expression is correlated with a poor and good prognosis in ERα-negative and ERα-positive BCs, respectively.
    [Show full text]